• 1. Evolving better nanoparticles: Genetic algorithms for optimising cluster geometries
  Dalton Trans., 2003, 4193-4207
• 2. Emerging investigator series: bacteriophages as nano engineering tools for quality monitoring and pathogen detection in water and wastewater
  Fereshteh Bayat Environ. Sci.: Nano, 2021,8, 367-389
• 3. Excitation energies from ground-state density-functionals by means of generator coordinates
  A. B. F. da Silva,K. Capelle Phys. Chem. Chem. Phys., 2009,11, 4564-4569
• 4. Establishing empirical design rules of nucleic acid templates for the synthesis of silver nanoclusters with tunable photoluminescence and functionalities towards targeted bioimaging applications?
  Jason Y. C. Lim,Yong Yu,Guorui Jin,Kai Li,Yi Lu,Jianping Xie Nanoscale Adv., 2020,2, 3921-3932
• 5. EWOD-driven droplet microfluidic device integrated with optoelectronic tweezers as an automated platform for cellular isolation and analysis?
  Gaurav J. Shah,Eric P.-Y. Chiou,Ming C. Wu,Chang-Jin “CJ” Kim Lab Chip, 2009,9, 1732-1739

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Nitrobenzoic acids and derivatives
• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Benzoic acids and derivatives Nitrobenzoic acids and derivatives

Recent Advances in the Application of 5-Iodo-2-nitrobenzoic Acid (CAS: 35674-28-3) in Chemical Biology and Pharmaceutical Research

5-Iodo-2-nitrobenzoic acid (CAS: 35674-28-3) is a versatile chemical compound that has garnered significant attention in recent years due to its unique structural properties and broad applicability in chemical biology and pharmaceutical research. This compound, characterized by its nitro and iodo functional groups, serves as a critical intermediate in the synthesis of various bioactive molecules and has been employed in diverse research applications, including drug discovery, proteomics, and materials science. Recent studies have further elucidated its potential in targeted therapies and diagnostic applications, making it a focal point for ongoing investigations.

One of the most notable advancements in the use of 5-Iodo-2-nitrobenzoic acid is its role in the development of novel covalent inhibitors. Researchers have leveraged its electrophilic properties to design inhibitors that selectively target cysteine residues in proteins, a strategy that has shown promise in the treatment of diseases such as cancer and autoimmune disorders. For instance, a 2023 study published in the *Journal of Medicinal Chemistry* demonstrated the compound's efficacy in inhibiting key enzymes involved in tumor progression, highlighting its potential as a therapeutic agent.

In addition to its therapeutic applications, 5-Iodo-2-nitrobenzoic acid has been instrumental in proteomics research. Its ability to form stable covalent bonds with thiol groups has made it a valuable tool for labeling and identifying proteins in complex biological samples. Recent work published in *Analytical Chemistry* showcased its use in mass spectrometry-based proteomics, where it enabled the precise mapping of protein interactions and post-translational modifications. This advancement has significant implications for understanding disease mechanisms and identifying new biomarkers.

Another emerging area of research involves the use of 5-Iodo-2-nitrobenzoic acid in the development of fluorescent probes and imaging agents. By incorporating this compound into fluorogenic scaffolds, scientists have created probes capable of detecting reactive oxygen species (ROS) and other biologically relevant molecules in real time. A 2022 study in *Chemical Communications* reported the synthesis of a ROS-sensitive probe based on 5-Iodo-2-nitrobenzoic acid, which exhibited high selectivity and sensitivity in cellular imaging experiments. Such probes hold great potential for diagnostic and therapeutic monitoring applications.

Despite these advancements, challenges remain in optimizing the pharmacokinetic and safety profiles of derivatives based on 5-Iodo-2-nitrobenzoic acid. Recent efforts have focused on modifying its structure to enhance bioavailability and reduce off-target effects. For example, a 2023 preprint on *bioRxiv* described the synthesis of water-soluble analogs with improved stability and reduced cytotoxicity, paving the way for their use in clinical settings. These developments underscore the importance of continued research to fully harness the compound's potential.

In conclusion, 5-Iodo-2-nitrobenzoic acid (CAS: 35674-28-3) continues to be a valuable tool in chemical biology and pharmaceutical research, with recent studies expanding its applications in drug discovery, proteomics, and diagnostics. As researchers uncover new ways to exploit its unique properties, this compound is poised to play an even greater role in advancing biomedical science. Future work should focus on addressing existing limitations and exploring novel applications to maximize its impact on human health.

• 3113-72-2(5-Methyl-2-nitrobenzoic acid)
• 5437-38-7(2-Nitro-m-toluic Acid)
• 95192-62-4(Benzoicacid, 2-iodo-4,6-dinitro-)
• 4315-09-7(4-Nitrobenzene-1,3-dicarboxylic acid)
• 21161-11-5(2-Nitroisophthalic acid)
• 95192-58-8(Benzoic acid,4-iodo-2,6-dinitro-)
• 52095-18-8(3,5-dimethyl-2-nitrobenzoic acid)
• 6313-17-3(3-iodo-5-nitro-benzoic acid)
• 552-16-9(2-Nitrobenzoic acid)
• 116529-62-5(4-Iodo-2-nitrobenzoic acid)